Table 1.
Intrinsic and Extrinsic DNA-Damaging Agents, and the Types and Consequences of Associated DNA Damage
Source | Damaging Agent or Event | Major Form(s) of Damage | Primary Consequence on DNA Structure and Transactions | |
---|---|---|---|---|
Intrinsic | spontaneous hydrolysis | uracil | little structural impact; causes C→T mutations | |
AP sites | increased phosphodiester backbone flexibility, possible structural distortion; non-coding, mutagenic; polymerase block | |||
replication mistakes | mispair | some DNA conformational effects, depending on mispair; mutagenic | ||
indel | conformational effect (hairpin loop); MSI | |||
replicative stress | DSBs | fork collapse, genomic instability | ||
reactive endogenous chemicals | ROS | base modifications, AP sites, SSBs | depending on the damage, mutagenic or polymerase block (see text for examples) | |
SAM | methylated bases, e.g., O6-methylguanine | little structural impact; causes G→A mutations | ||
aldehydes (e.g., malondialdehyde) | base adducts, ICLs | helix-distortion, covalent bridge; polymerase block; possible error-prone bypass | ||
Extrinsic | radiation | UV | CPDs, 6-4PPs | helix-distorting; polymerase block; possible error-prone bypass |
IR | base modifications, SSBs and DSBs | depending on the damage, mutagenic or polymerase block; genomic instability | ||
environmental chemicals | B[a]P | base adduct | helix-distorting; polymerase block; possible G→T mutations | |
AFB1 | base adducts | helix-distortion; polymerase block; possible error-prone bypass | ||
chemotherapeutic agents | cisplatin | base adducts, intra and interstrand crosslinks | helix-distortion; polymerase block | |
etoposide, doxorubicin | DSBs, protein-DNA adduct | replication and transcription block |